Transparency disclosures

As a leading global healthcare company, we engage with a variety of stakeholders, including public officials, healthcare professionals, patient organisations and business partners. In all our interactions, our first priority is to live up to our responsibilities and all regulatory requirements.

Our position on transparency is clear; we will be transparent and accountable for how we operate and the transactions that take place when and where we work. Our position is a part of Novo Nordisk’s company values expressed in the Novo Nordisk Way, in our policies and how we earn and retain trust and confidence.


Disclosure of support

In accordance with industry guidelines in Europe, Novo Nordisk has made details about how we work with patient groups in Europe publicly available. This includes a list of collaboration projects, a short description of the nature of the support, and any financial support.


Codes of practice on relationships between the pharmaceutical industry and patient organisations

EFPIA Code of Practice (PDF)

*European Federation of Pharmaceutical Industries and Associations

Patient Group donations 

HQ Donations IDF

HQ Donations IDF Europe

HQ Donations IDF Africa


HQ Donations IAPO

HQ Donations Other